Last reviewed · How we verify

NCT04328870

Fluid Absorption in Patients Undergoing Operative Hysteroscopy; Results From a Prospective Controlled Study

Completed NA Last updated 31 March 2020
What this trial tests

NA trial testing oxytocin and spinal anesthesia in Fluid Overload in 88 participants. Completed in 30 September 2019.

Timeline
20 May 2018
Primary endpoint
30 September 2019
30 September 2019

Quick facts

Lead sponsorUniversity of Jordan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designfactorial
Maskingnone
Primary purposeprevention
Enrollment88
Start date20 May 2018
Primary completion30 September 2019
Estimated completion30 September 2019
Sites1 location across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

University of Jordan

Who can join

Adults 18 to 49, female only, with Fluid Overload. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine if combining intravenous oxytocin infusion and spinal anesthesia will reduce the amount of glycine absorption in patients undergoing operative hysteroscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fluid Overload

Currently open trials in the same condition.

Other University of Jordan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04328870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing